11 November 2016

The Late Medical Effects of Cancer Treatments – Royal College of Physicians

London, UK

This one-day conference will focus on the medical late effects of cancer treatments in cancer survivors. Iron overload has been indicated in cancer survivors as a result of treatments and as such FerriScan may play a role in the monitoring and management of these patients.

Resonance Health’s Marketing Director, Melanie Baxter, and Research Consultant, Dr Susanna Katay-Davies (MD), will be attending the conference. It will provide the opportunity to discuss best practice and the role of FerriScan in this field.

To arrange a meeting or for further information please email

For more information on the conference please click here…